Alexion Pharmaceuticals, Inc. (ALXN) financial statements (2020 and earlier)

Company profile

Business Address 121 SEAPORT BOULEVARD
BOSTON, MA 02210
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,2161,5641,4741,2931,3851,962
Cash and cash equivalents2,1711,3665849661,010944
Short-term investments441988903273751,018
Receivables1,116922727650533433
Inventory, net of allowances, customer advances and progress billings577473460375290176
Inventory577473460375290176
Other current assets433426293260218189
Other undisclosed current assets     36
Total current assets:4,3413,3852,9542,5782,4252,796
Noncurrent Assets
Property, plant and equipment1,1481,4721,3251,036697392
Intangible assets, net (including goodwill)8,4488,6798,9929,3409,756841
Goodwill5,0375,0375,0375,0375,048254
Intangible assets, net (excluding goodwill)3,4103,6413,9544,3034,708587
Restricted cash and investments0     
Other noncurrent assets671397312299255138
Other undisclosed noncurrent assets207    35
Total noncurrent assets:10,47410,54710,62910,67510,7081,406
TOTAL ASSETS:14,81513,93213,58313,25313,1334,202
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:868698710572461623
Accounts payable  71645744
Accrued liabilities 171639508403395
Employee-related liabilities 170   88
Taxes payable 24   95
Other undisclosed accounts payable and accrued liabilities868332    
Debt1279416716717548
Restructuring reserve 4    
Business combination, contingent consideration, liability 98 24  
Deferred revenue and credits16372159
Contract with customer, liability3
Other liabilities963459236261
Other undisclosed current liabilities 242   (183)
Total current liabilities:1,0911,174953823718607
Noncurrent Liabilities
Long-term debt and lease obligation2,4072,5022,7212,8883,28110
Long-term debt, excluding current maturities2,4072,5022,7212,8883,28110
Liabilities, other than long-term debt46817315911062684
Deferred tax liabilities, net   5297
Liability, pension and other postretirement and postemployment benefits 1819202324
Other liabilities280156140907353
Business combination, contingent consideration, liability188     
Other undisclosed noncurrent liabilities482918858738249200
Total noncurrent liabilities:3,3573,5933,7383,7364,156293
Total liabilities:4,4484,7674,6904,5594,875900
Stockholders' equity
Stockholders' equity attributable to parent10,3679,1658,8938,6948,2593,302
Common stock    00
Treasury stock, value(2,073)(1,690)(1,605)(1,141)(711)(383)
Additional paid in capital8,7388,5398,2907,9577,7272,592
Accumulated other comprehensive income (loss)(48)(10)(34)606257
Retained earnings3,7512,3262,2421,8181,1801,036
Total stockholders' equity:10,3679,1658,8938,6948,2593,302
TOTAL LIABILITIES AND EQUITY:14,81513,93213,58313,25313,1334,202

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues4,7364,1313,5513,0822,6032,234
Revenue, net3,5513,0842,6042,234
Cost of revenue
(Cost of Goods and Services Sold)
(377)(374)(454)(258)(233)(174)
Gross profit:4,3593,7573,0972,8242,3692,060
Operating expenses(2,736)(3,487)(2,470)(2,159)(1,834)(1,191)
Other undisclosed operating income   22 
Operating income:1,623270627667537869
Nonoperating income17119696
Investment income, nonoperating(4)65191198
Foreign currency transaction gain (loss), before tax  0(5)1(2)
Other nonoperating income56    
Interest and debt expense(81)(98)(98)(97)(48)(3)
Income from continuing operations before income taxes:1,544242548576498872
Income tax expense(74)(165)(105)(177)(354)(215)
Net income available to common stockholders, diluted:1,47078443399144657

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:1,47078443399144657
Other comprehensive income (loss) (7)2 32
Other undisclosed comprehensive loss(7)     
Comprehensive income:1,46371445399147659
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(48)32(97)(2)278
Comprehensive income, net of tax, attributable to parent:1,415102348397150737

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: